-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Cutera (NASDAQ:CUTR) Shares Up 6.4%
Cutera (NASDAQ:CUTR) Shares Up 6.4%
Cutera, Inc. (NASDAQ:CUTR – Get Rating) shot up 6.4% on Friday . The company traded as high as $46.35 and last traded at $46.12. 10,166 shares were traded during mid-day trading, a decline of 96% from the average session volume of 272,935 shares. The stock had previously closed at $43.34.
Wall Street Analyst Weigh In
A number of brokerages have recently weighed in on CUTR. Piper Sandler lowered their price target on Cutera from $65.00 to $55.00 and set an "overweight" rating for the company in a report on Friday, August 5th. TheStreet downgraded Cutera from a "c-" rating to a "d+" rating in a research note on Thursday, July 7th. StockNews.com upgraded Cutera to a "sell" rating in a research note on Friday, September 2nd. Finally, Maxim Group restated a "buy" rating and set a $80.00 price objective on shares of Cutera in a research note on Friday, August 5th.
Get Cutera alerts:Cutera Stock Performance
The stock has a market capitalization of $903.03 million, a P/E ratio of -12.38 and a beta of 1.84. The stock has a 50 day moving average of $47.51 and a 200 day moving average of $49.36. The company has a debt-to-equity ratio of 12.56, a quick ratio of 3.83 and a current ratio of 4.36.
Cutera (NASDAQ:CUTR – Get Rating) last announced its quarterly earnings results on Thursday, August 4th. The medical device company reported ($0.24) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.23) by ($0.01). Cutera had a negative return on equity of 151.43% and a negative net margin of 27.62%. The business had revenue of $64.22 million for the quarter, compared to analyst estimates of $63.42 million. During the same quarter last year, the firm posted $0.39 EPS. The company's revenue was up 9.6% compared to the same quarter last year. Equities analysts predict that Cutera, Inc. will post -1.88 EPS for the current year.Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in the business. Prelude Capital Management LLC boosted its position in Cutera by 19,653.8% during the 2nd quarter. Prelude Capital Management LLC now owns 908,475 shares of the medical device company's stock worth $1,173,000 after acquiring an additional 903,876 shares during the period. ExodusPoint Capital Management LP acquired a new stake in shares of Cutera in the second quarter valued at $883,000. Goldman Sachs Group Inc. lifted its holdings in shares of Cutera by 2.5% in the second quarter. Goldman Sachs Group Inc. now owns 32,473 shares of the medical device company's stock valued at $1,218,000 after buying an additional 778 shares during the period. Jane Street Group LLC lifted its holdings in shares of Cutera by 105.4% in the second quarter. Jane Street Group LLC now owns 30,124 shares of the medical device company's stock valued at $1,129,000 after buying an additional 15,457 shares during the period. Finally, Thrivent Financial for Lutherans lifted its holdings in shares of Cutera by 22.1% in the second quarter. Thrivent Financial for Lutherans now owns 16,238 shares of the medical device company's stock valued at $609,000 after buying an additional 2,935 shares during the period.
About Cutera
(Get Rating)
Cutera, Inc, a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis.
Featured Stories
- Get a free copy of the StockNews.com research report on Cutera (CUTR)
- This Is A Memorable Time To Buy Into Micron Technology
- Thor Industries Hammers Out A Bottom
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
- Let Paychex Stock Work Hard For You
- Declining Profits Challenge the CarMax Value Proposition
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.
Cutera, Inc. (NASDAQ:CUTR – Get Rating) shot up 6.4% on Friday . The company traded as high as $46.35 and last traded at $46.12. 10,166 shares were traded during mid-day trading, a decline of 96% from the average session volume of 272,935 shares. The stock had previously closed at $43.34.
卡特拉公司(纳斯达克代码:Cutr-Get Rating)周五暴涨6.4%。该公司股价一度高达46.35美元,最新报46.12美元。午盘成交量为10,166股,较272,935股的平均成交量下降96%。该股此前收盘价为43.34美元。
Wall Street Analyst Weigh In
华尔街分析师也加入进来
A number of brokerages have recently weighed in on CUTR. Piper Sandler lowered their price target on Cutera from $65.00 to $55.00 and set an "overweight" rating for the company in a report on Friday, August 5th. TheStreet downgraded Cutera from a "c-" rating to a "d+" rating in a research note on Thursday, July 7th. StockNews.com upgraded Cutera to a "sell" rating in a research note on Friday, September 2nd. Finally, Maxim Group restated a "buy" rating and set a $80.00 price objective on shares of Cutera in a research note on Friday, August 5th.
最近,许多券商都加入了Cutr的行列。派珀·桑德勒在8月5日周五的一份报告中将他们对Cutera的目标价从65.00美元下调至55.00美元,并对该公司设定了“增持”评级。华尔街在7月7日星期四的一份研究报告中将Cutera的评级从“c-”下调至“d+”。在9月2日星期五的一份研究报告中,StockNews.com将Cutera的评级上调至“卖出”。最后,Maxim Group在8月5日星期五的一份研究报告中重申了“买入”评级,并为Cutera的股票设定了80.00美元的目标价。
Cutera Stock Performance
Cutera股票表现
The stock has a market capitalization of $903.03 million, a P/E ratio of -12.38 and a beta of 1.84. The stock has a 50 day moving average of $47.51 and a 200 day moving average of $49.36. The company has a debt-to-equity ratio of 12.56, a quick ratio of 3.83 and a current ratio of 4.36.
该股市值为9.0303亿美元,市盈率为-12.38,贝塔系数为1.84。该股的50日移动均线切入位为47.51美元,200日移动均线切入位为49.36美元。该公司的负债权益比率为12.56,速动比率为3.83,流动比率为4.36。
Institutional Inflows and Outflows
机构资金流入和流出
A number of institutional investors have recently added to or reduced their stakes in the business. Prelude Capital Management LLC boosted its position in Cutera by 19,653.8% during the 2nd quarter. Prelude Capital Management LLC now owns 908,475 shares of the medical device company's stock worth $1,173,000 after acquiring an additional 903,876 shares during the period. ExodusPoint Capital Management LP acquired a new stake in shares of Cutera in the second quarter valued at $883,000. Goldman Sachs Group Inc. lifted its holdings in shares of Cutera by 2.5% in the second quarter. Goldman Sachs Group Inc. now owns 32,473 shares of the medical device company's stock valued at $1,218,000 after buying an additional 778 shares during the period. Jane Street Group LLC lifted its holdings in shares of Cutera by 105.4% in the second quarter. Jane Street Group LLC now owns 30,124 shares of the medical device company's stock valued at $1,129,000 after buying an additional 15,457 shares during the period. Finally, Thrivent Financial for Lutherans lifted its holdings in shares of Cutera by 22.1% in the second quarter. Thrivent Financial for Lutherans now owns 16,238 shares of the medical device company's stock valued at $609,000 after buying an additional 2,935 shares during the period.
一些机构投资者最近增持或减持了该业务的股份。Prelude Capital Management LLC在第二季度将其在Cutera的头寸增加了19,653.8%。Prelude Capital Management LLC在此期间额外收购了903,876股,现在拥有这家医疗器械公司908,475股股票,价值1,173,000美元。ExodusPoint Capital Management LP在第二季度收购了Cutera的新股份,价值883,000美元。高盛股份有限公司在第二季度增持了2.5%的Cutera股票。高盛股份有限公司目前持有这家医疗器械公司32,473股股票,价值1,218,000美元,在此期间又购买了778股。简街集团在第二季度增持了105.4%的卡特拉股票。简街集团现在拥有30,124股这家医疗设备公司的股票,价值1,129,000美元,在此期间又购买了15,457股。最后,Thrient Financial for Lutherans在第二季度增持了22.1%的Cutera股票。ThriventFinancial for Lutherans现在拥有这家医疗设备公司16,238股票,价值609,000美元,在此期间又购买了2,935股票。
About Cutera
关于Cutera
(Get Rating)
(获取评级)
Cutera, Inc, a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis.
Cutera,Inc.是一家医疗器械公司,研究、开发、制造、营销激光和基于能量的美学系统,并为全球从业者提供服务。该公司推出了Secret PRO,这是一种利用分数二氧化碳进行皮肤表面重塑和射频微针进行深层真皮重塑的设备;truSculpt flex,一种生物电肌肉刺激设备,可以治疗各种健康水平的患者;EXCEL V+,一种血管和良性色素病变治疗平台;truSculpt ID,用于非手术身体造型市场;Secret RF,一种用于组织凝固和止血的分数射频微针系统。
Featured Stories
专题报道
- Get a free copy of the StockNews.com research report on Cutera (CUTR)
- This Is A Memorable Time To Buy Into Micron Technology
- Thor Industries Hammers Out A Bottom
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
- Let Paychex Stock Work Hard For You
- Declining Profits Challenge the CarMax Value Proposition
- 免费获取StockNews.com关于Cutera的研究报告(Cutr)
- 这是买入美光科技的难忘时刻
- 雷神工业走出谷底
- Keurig Dr Pepper与规模更大的竞争对手可口可乐(Coke&Pepsi)相比如何?
- 让Paychex股票为您努力工作
- 利润下降对CarMax价值主张的挑战
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.
接受Cutera Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Cutera和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧